Oxidatively Modified LDL and Atherosclerosis: An Evolving Plausible Scenario

Critical Reviews in Food Science and Nutrition

Volumn 36, Issue 4, 1996, Pages 341-355

  Jialal, I ^a,b   Fuller, Cindy J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Alpha tocopherol; Ascorbic acid; Atherosclerosis; Beta carotene; Low density lipoprotein; Probucol

Indexed keywords

ANIMALIA;

ANTIOXIDANT; LOW DENSITY LIPOPROTEIN;

ARTERIOSCLEROSIS; DIET; HUMAN; LIPID PEROXIDATION; METABOLISM; REVIEW;

ANTIOXIDANTS; ARTERIOSCLEROSIS; DIET; HUMANS; LIPID PEROXIDATION; LIPOPROTEINS, LDL;

EID: 0030124223     PISSN: 10408398     EISSN: None     Source Type: Journal    
DOI: 10.1080/10408399609527729     Document Type: Article

References (115)

1. Brown, M. S. and Goldstein, J. L., Lipoprotein metabolism in the macrophage, Annu. Rev. Biochem., 52, 223, 1983.
2. Parthasarathy, S. and Rankin, S. M., Role of oxidized low density lipoprotein in atherogenesis, Prog. Lipid Res., 31, 127, 1992.
3. Steinbrecher, U. P., Parthasarathy, S., Leake, D. S., Witztum, J. L., and Steinberg, D., Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids, Proc. Natl. Acad. Sci. U.S.A., 81, 3883, 1984.
4. van Hinsbergh, V. W. M., Schefler, M., Havekes, L., and Kempen, H. J. M., Role of endothelial cells and their products in the modification of low density lipoproteins, Biochim. Biophys. Acta, 878, 49, 1986.
5. Navab, M., Imes, S. S., Hama, S. Y., Hough, G. P., Ross, L. A., Bork, R. W., Valente, A. J., Berliner, J. A., Drinkwater, D. C., Laks, H., and Fogelman, A. M., Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein, J. Clin. Invest., 88, 2039, 1991.
6. Esterbauer, H., Jürgens, G., Quehenberger, O., and Koller, E., Autoxidation of human low density lipoprotein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes, J. Lipid Res., 28, 495, 1987.
7. Jialal, I., Freeman, D. A., and Grundy, S. M., Varying susceptibility of different low density lipoproteins to oxidative modification, Arterioscler. Thromb., 11, 482, 1991.
8. Young, S. G. and Parthasarathy, S., Why are low-density lipoproteins artherogenic?, West J. Med., 160, 153, 1994.
9. Witztum, J. L. and Steinberg, D., Role of oxidized low density lipoprotein in atherogenesis, J. Clin. Invest., 88, 1785, 1991.
10. Gerrity, R. G., The role of the monocyte in atherogenesis. I. Transition of blood-borne monocytes into foam cells in fatty lesions, Am. J. Pathol., 103, 181, 1981.
11. Morel, D. W., Hessler, J. R., and Chisolm, G. M., Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid, J. Lipid Res., 24, 1070, 1983.
12. Berliner, J. A., Territo, M. C., Sevanian, A., Ramin, S., Kim, J. A., Bamshad, B., Esterson, M., and Fogelman, A. M., Minimally modified low density lipoprotein stimulates monocyte-endothelial interactions, J. Clin. Invest., 85, 1260, 1990.
13. Parthasarathy, S., Fong, L. G., Quinn, M. T., and Steinberg, D., Oxidative modification of LDL: comparison between cell-mediated and copper-mediated modification, Eur. Heart J., 11(Suppl. E), 83, 1990.
14. Cushing, S. D., Berliner, J. A., Valente, A. J., Territo, M. C., Navab, M., Parhami, F., Gerrity, R., Schwartz, C. J., and Fogelman, A. M., Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells, Proc. Natl. Acad. Sci. U.S.A., 87, 5134, 1990.
15. Cybulski, M. I. and Gimbrone, M. A., Jr., Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science (Washington, D.C.), 251, 788, 1990.
16. Kume, N., Cybulski, M. I., and Gimbrone, M. A., Jr., Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells, J. Clin. Invest., 90, 1138, 1992.
17. Quinn, M. T., Parthasarathy, S., and Steinberg, D., Endothelial cell-derived chemotactic activity for mouse peritoneal macrophages and the effects of modified forms of low density lipoprotein, Proc. Natl. Acad. Sci. U.S.A., 82, 5949, 1985.
18. Quinn, M. T., Parthasarathy, S., Fong, L. G., and Steinberg, D., Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis, Proc. Natl. Acad. Sci. U.S.A., 84, 2995, 1987.
19. Quinn, M. T., Parthasarathy, S., and Steinberg, D., Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis, Proc. Natl. Acad. Sci. U.S.A., 85, 2805, 1988.
20. Rajavashisth, T. B., Andalibi, A., Territo, M. C., Berliner, J. A., Navab, M., Fogelman, A. M., and Lusis, A. J., Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low density lipoproteins, Nature (London), 344, 254, 1990.
21. Maiden, L. T., Chait, A., Raines, E. W., and Ross, R., The influence of oxidatively modified low density lipoproteins on expression of platelet derived growth factor by human monocyte derived macrophages, J. Biol. Chem., 266, 13901, 1991.
22. Stiko-Rahm, A., Hultgärdgh-Nilsson, A., Regenström, J., Hamsten, A., and Nilsson, J., Native and oxidized LDL enhances production of PDGF AA and the surface expression of PDGF receptors in cultured human smooth muscle cells, Arterioscler. Thromb., 12, 1099, 1992.
23. Triau, J. E., Meydani, S. N., and Sehaefer, E. J., Oxidized low density lipoprotein stimulates prostacyclin production by adult human vascular endothelial cells, Arteriosclerosis, 8, 810, 1988.
24. Ek, B. and Humble, L., Correlation between oxidation of low density lipoproteins and prostacyclin synthesis in cultured smooth muscle cells, Biochem. Pharmacol., 41, 695, 1991.
25. Yokode, M., Kita, T., Arai, H., Kawai, C., Narumiya, S., and Fujiwara, M., Cholesterol ester accumulation in macrophages with low density lipoprotein pretreated with cigarette smoke, Proc. Natl. Acad. Sci. U.S.A., 85, 2344, 1988.
26. Hamsten, A., deFaire, U., Walldius, G., Dahlen, G., Szamosi, A., Landou, C., Blombäck, M., and Wiman, B., Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet, i, 3, 1987.
27. Latron, Y., Chautan, M., Anfosso, F., Alessi, M. C., Nalbone, G., Lafort, H., and Julian-Vague, I., Stimulating effect of oxidized low density lipoproteins on plasminogen activator inhibitor-1 synthesis by endothelial cells, Anerioscler. Thromb., 11, 1821, 1991.
28. Jacobs, M., Plane, F., and Bruckdorfer, K. R., Native and oxidized low-density lipoproteins have different inhibitory effects on endothelium-derived relaxing factor in the rabbit aorta, Br. J. Pharmacol., 100, 21, 1990.
29. Haberland, M. E., Fong, D., and Cheng, L., Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits, Science (Washington, D.C.), 241, 215, 1988.
30. Yla-Herttuala, S., Palinski, W., Rosenfeld, M. E., Parthasarathy, S., Carew, T. E., Butler, S., Witztum, J. L., and Steinberg, D., Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest., 84, 1086, 1989.
31. Palinski, W., Rosenfeld, M. E., Ylä-Herttuala, S., Gurtner, G. C., Socher, S. S., Butler, S. W., Parthasarathy, S., Carew, T. E., Steinberg, D., and Witztum, J. L., Low density lipoprotein undergoes oxidative modification in vivo, Proc. Natl. Acad. Sci. U.S.A., 86, 1372, 1989.
32. Lecomte, E., Artur, Y., Chancerelle, Y., Herbeth, B., Galteau, M.-M., Jeandel, C., and Siest, G., Malondialdehyde adducts to, and fragmentation of, apolipoprotein B from human plasma, Clin. Chim. Acta, 218, 39, 1993.
33. Avogaro, P., Bon, G. B., and Cazzolato, G., Presence of a modified low density lipoprotein in humans, Arteriosclerosis, 8, 79, 1988.
34. Palinski, W., Ylä-Herttuala, S., Rosenfeld, M. E., Butler, S. W., Socher, S. A., Parthasarathy, S., Curtiss, L. K., and Witztum, J. L., Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein, Arteriosclerosis, 10, 325, 1990.
35. Salonen, J. T., Ylä-Herttuala, S., Yamamoto, R., Butler, S., Korpela, H., Salonen, R., Nyssönen, K., Palinski, W., and Witztum, J. L., Auto-antibody against oxidized LDL and progression of carotid atherosclerosis, Lancet, 339, 883, 1992.
36. Regnström, J., Nilsson, J., Tornvall, P., Landou, C., and Hamsten, A., Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man, Lancet, 339, 1183, 1992.
37. Carew, T. E., Schwenke, D. C., and Steinberg, D., Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: Evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit, Proc. Natl. Acad. Sci. U.S.A., 84, 7725, 1987.
38. Morel, D. W. and Chisolm, G. M., Antioxidant treatment of diabetic rats inhibits lipoprotein oxidation and cytotoxicity, J. Lipid Res., 30, 1827, 1989.
39. Björkhem, I., Henriksson-Freyschuss, A., Breuer, O., Diczfalusy, U., Berglund, L., and Henriksson, P., The antioxidant butylated hydroxytoluene protects against atherosclerosis, Arterioscler. Thromb., 11, 15, 1991.
40. Sparrow, C. P., Doebber, T. W., Olszewski, J., Wu, M. S., Ventre, J., Stevens, K. A., and Chao, Y., Low density lipoprotein is protected from oxidation and the progression of atherosclerosis is slowed in cholesterol-fed rabbits by the antioxidant N,N′-diphenyl-phenylenediamine, J. Clin. Invest., 89, 1885, 1992.
41. Hirose, M., Shibata, M., Hagiwara, A., Imaida, K., and Ito, N., Chronic toxicity of butylated hydroxytoluene in Wistar rats, Food Cosmet. Toxicol., 19, 147, 1981.
42. Physicians' Desk Reference, 44th ed., Medical Economics Company, Oradell, NJ, 1990.
43. Kita, T., Nagano, Y., Yokode, M., Ishii, K., Kume, N., Ooshima, A., Yoshida, H., and Kawai, C., Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia, Proc. Natl. Acad. Sci. U.S.A., 84, 5928, 1987.
44. Chisolm, G. M. and Morel, D. W., Lipoprotein oxidation and cytotoxicity. Effect of probucol on streptozotocin-treated rats, Am. J. Cardiol., 62, 20B, 1988.
45. Parthasarathy, S., Young, S. G., Witztum, J. L., Pittman, R. C., and Steinberg, D., Probucol inhibits oxidative modification of low density lipoprotein, J. Clin. Invent., 77, 641, 1986.
46. Jialal, I. and Grundy, S. M., Preservation of the endogenous antioxidants in low density lipoprotein by ascorbate but not probucol during oxidative modification, J. Clin. Invest., 87, 597, 1991.
47. Cristol, L. S., Jialal, I., and Grundy, S. M., Effect of low-dose probucol therapy on LDL oxidation and the plasma lipoprotein profile in male volunteers, Atherosclerosis, 97, 11, 1992.
48. Naruszewicz, M., Selinger, E., Dufour, R., and Davignon, J., Probucol protects lipoprotein (a) against oxidative modification, Metabolism, 41, 1225, 1992.
49. Grundy, S. M., Goodman, D. S., Rifkind, B. M., and Cleeman, J. L., The place of HDL in cholesterol management: a perspective from the National Cholesterol Education Program, Arch. Intern. Med., 149, 5050, 1989.
50. Walter, P., Supraphysiological dosages of vitamins and their implications in humans, Experientia, 47, 178, 1991.
51. Kappus, H. and Diplock, A. T., Tolerance and safety of vitamin E: A toxicological position report, Free Radical Biol. Med., 13, 55, 1992.
52. Hathcock, J. N., Hattan, D. G., Jenkins, M. Y., McDonald, J. T., Sundaresan, P. R., and Wilkening, V. L., Evaluation of vitamin A toxicity, Am. J. Clin. Nutr., 52, 183, 1990.
53. National Research Council: Recommended Dietary Allowances, 10th ed., National Academy Press, Washington, D.C., 1989.
54. Esterbauer, H., Dieber-Rotheneder, M., Waeg, G., Puhl, H., and Tatzber, F., Endogenous antioxidants and lipoprotein oxidation, Biochem. Soc. Trans., 18, 1059, 1990.
55. Gey, K. F., Puska, P., Jordon, P., and Moser, U., Inverse correlation between vitamin E and mortality from ischemic heart disease in crosscultural epidemiology, Am. J. Clin. Nutr., 53, 326, 1992.
56. Riemersma, R. A., Wood, D. A., MacIntyre, C. C. A., Elton, R. A., Gey, K. F., and Oliver, M. F., Risk of angina pectoris and plasma concentrations of vitamins A. Cl, and E and carotene, Lancet, 337, 1, 1991.
57. Stampfer, M. J., Hennekens, C. H., Manson, J. E., Colditz, G. A., Rosner, B., and Willett, W. C., Vitamin E consumption and the risk of coronary disease in women, N. Engl. J. Med., 328, 1444, 1993.
58. Rimm, E. B., Stampfer, M. J., Ascherio, A., Giovannucci, E., Colditz, G. A., and Willett, W. C., Vitamin E consumption and the risk of coronary heart disease in men, N. Engl. J. Med., 328, 1450, 1993.
59. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers, N. Engl. J. Med., 330, 1029, 1994.
60. Janero, D. R., Therapeutic potential of vitamin E in the pathogenesis of spontaneous atherosclerosis, Free Radical Biol. Med., 11, 129, 1991.
61. Verlangieri, A. J. and Bush, M. J., Effects of d-a-tocopherol supplementation on experimentally induced primate atherosclerosis, J. Am. Coll. Nutr., 11, 131, 1992.
62. Williams, R. J., Motteram, J. M., Sharp, C. H., and Gallagher, P. J., Dietary vitamin E and the attenuation of lesion development in modified Watanabe rabbits, Atherosclerosis, 94, 153, 1992.
63. Esterbauer, H., Dieber-Rotheneder, M., Striegl, G., and Waeg, G., Role of vitamin E in preventing the oxidation of low-density lipoprotein, Am. J. Clin. Nutr., 53, 314S, 1991.
64. Princen, H. M. G., van Poppel, G., Vogelezang, C., Buytenhek, R., and Kok, F. J., Supplementation with vitamin E but not β-carotene in vivo protects low density lipoprotein from lipid peroxidation in vitro: effect of cigarette smoking, Arterioscler. Thromb., 12, 554, 1992.
65. Dieber-Rotheneder, M., Puhl, H., Waeg, G., Striegl, G., and Esterbauer, H., Effect of oral supplementation with D-a-tocopherol on the vitamin E content of human low density lipoproteins and resistance to oxidation, J. Lipid Res., 32, 1325, 1991.
66. Jialal, I. and Grundy, S. M., Effect of dietary supplementation with alpha-tocopherol on the oxidative modification of low density lipoprotein, J. Lipid Res., 33, 899, 1992.
67. Jialal, I. and Scaccini, C., Antioxidants and atherosclerosis, Curr. Op. Lipidol., 3, 324, 1992.
68. Reaven, P. D. and Witztum, J. L., Comparison of supplementation of RRR-α-tocopherol and racemic α-tocopherol in humans: effects on lipid levels and lipoprotein susceptibility to oxidation, Arterioscler. Thromb., 13, 601, 1993.
69. Machlin, L. J. and Bendich, A., Free radical tissue damage: protective role of antioxidant nutrients, FASEB J., 1, 441, 1987.
70. Packer, J. E., Slater, T. F., and Willson, R. L., Direct observation of a free radical interaction between vitamin E and vitamin C, Nature (London), 278, 737, 1979.
71. Frei, B., England, L., and Ames, B. N., Ascorbate is an outstanding antioxidant in human blood plasma, Proc. Natl. Acad. Sci. U.S.A., 86, 6377, 1989.
72. Gey, K. F., Brubacher, G. B., and Stähelin, H. B., Plasma levels of antioxidant vitamins in relation to ischemic heart disease and cancer, Am. J. Clin. Nutr., 45, 1368, 1987.
73. Dubick, M., Hunter, G., Casey, S., and Keen, C., Aortic ascorbic acid, trace elements and superoxide dismutase activity in human aneurysmal and occlusive disease, Proc. Soc. Exp. Biol. Med., 184, 138, 1987.
74. Stankova, L., Riddle, M., Larned, J., Burry, K., Menashe, D., Hart, J., and Bigley, R., Plasma ascorbic concentrations and blood cell dehydroascorbate transport in patients with diabetes mellitus, Metabolism, 33, 347, 1984.
75. Chow, C. K., Thacker, R. R., Changchit, C., Bridges, R. B., Rehm, S. R., Humble, J., and Turbok, J., Lower levels of vitamin C and carotenes in plasma of cigarette smokers, J. Am. Coll. Nutr., 3, 305, 1986.
76. Ramirez, J. and Flowers, N., Leukocyte ascorbic acid and its relationship to coronary artery disease in man, Am. J. Clin. Nutr., 33, 2079, 1980.
77. Jialal, I., Vega, G. L., and Grundy, S. M., Physiologic levels of ascorbate inhibit the oxidative modification of low density lipoprotein, Atherosclerosis, 82, 185, 1990.
78. Frei, B., Ascorbic acid protects lipids in human plasma and low-density lipoprotein against oxidative damage, Am. J. Clin. Nuir., 54, 1113S, 1991.
79. Jialal, I. and Grundy, S. M., Influence of antioxidant vitamins on LDL oxidation, Ann. N. Y. Acad. Sci., 669, 237, 1992.
80. Harats, D., Ben-Nairn, M., Dabach, Y., Hollander, G., Havivi, E., Stein, O., and Stein, Y., Effect of vitamin C and E supplementation on susceptibility of plasma lipoproteins to peroxidation induced by acute smoking, Atherosclerosis, 85, 47, 1990.
81. Kalra, J., Chaudhary, A. K., and Prasad, K., Increased production of oxygen free radicals in cigarette smokers, Int. J. Exp. Pathol., 72, 1, 1991.
82. Krinsky, N. I., Cornwell, D. G., and Oncley, J. L., The transport of vitamin A and carotenoids in human plasma, Arch. Biochem. Biophys., 73, 233, 1958.
83. Chen, G. C. and Kane, J. P., Circular dichroism of lipoprotein lipids, Methods Enzymol., 128, 519, 1986.
84. Burton, G. W. and Ingold, K. U., β-Carotene. An unusual type of lipid antioxidant, Science (Washington, D.C.), 224, 569, 1984.
85. Manson, J. E., Gaziano, J. M., Jonas, M. A., and Hennekens, C. H., Antioxidants and cardiovascular disease: a review, J. Am. Coll. Nutr., 12, 426, 1993.
86. Kardinaal, A. F. M., Kok, F. J., Ringstad, J., Gomez-Arcéna, J., Mazaev, V. P., Kohlmeier, L., Martin, B. C., Aro, A., Kark, J. D., Delgado-Rodriguez, M., Riemersma, R. A., van Veer, P., Hultunen, J. K., and MartinMoreno, J. M., Antioxidants in adipose tissue and risk of myocardial infarction: the EURAMIC study, Lancet, 342, 1379, 1993.
87. Jialal, L, Norkus, E. P., Cristol, L., and Grundy, S. M., β-Carotene inhibits the oxidative modification of low-density lipoprotein, Biochim. Biophys. Acta, 1086, 134, 1991.
88. Naruszewicz, M., Selinger, E., and Davignon, J., Oxidative modification of lipoprotein (a) and the effect of β-carotene, Metabolism, 41, 1215, 1992.
89. Lavy, A., Ben Amotz, A., and Aviram, M., Preferential inhibition of LDL oxidation by the all-trans isomer of β-carotene in comparison with 9-cis-β-carotene, Eur. J. Clin. Chem. Clin. Biochem., 31, 83, 1993.
90. Fuller, C. J., Kent, R., Cristol, S., and Jialal, I., Effect of beta-carotene supplementation of LDL oxidation in healthy subjects. FASEB J., 7, A796, 1993 (abstract).
91. Reaven, P. D., Khouw, A., Beltz, W. F., Parthasa-rathy, S., and Witztum, J. L., Effect of dietary antioxidant combinations in humans: protection of LDL by vitamin E but not by ßcarotene, Arterioscler. Thromb., 13, 590, 1993.
92. Abbey, M., Nestel, P. J., and Baghurst, P. A., Antioxidant vitamins and low-density-lipoprotein oxidation, Am. J. Clin. Nutr., 58, 525, 1993.
93. Jialal, I. and Grundy, S. M., Effect of combined supplementation with alpha-tocopherol, ascorbate and β-carotene on low-density lipoprotein oxidation, Circulation, 88, 2780, 1993.
94. Jandak, J., Steiner, M., and Richardson, P. D., α-Tocopherol, an effective inhibitor of platelet adhesion, Blood, 73, 141, 1989.
95. Salonen, J. T., Salonen, R., Rinta-Kiikas, Schalch Kuukka, M., Korpela, H., Alfthan, G., Kantola, M., and Schialch, W., Effects of antioxidant supplementation on platelet function: a randomized pair-matched, placebo-controlled, double-blind trial in men with low antioxidant status, Am. J. Clin. Nutr., 53, 1222, 1991.
96. Boscoboinik, D., Szewczyk, A., Hensey, C., and Azzi, A., Inhibition of cell proliferation by α-tocopherol: role of protein kinase C, J. Biol. Chem., 266, 6188, 1991.
97. Keaney, J. F., Jr., Gaziano, J. M., Xu, A., Frei, B., Curran-Celentano, J., Shwaery, G. T., Loscalzo, J., and Vita, J. A., Low-dose α-tocopherol improves and high-dose α-tocopherol worsens endothelial vasodilator function in cholesterol fed rabbits. J. Clin. Invest., 93, 844, 1994.
98. Stocker, R., Bowry, V. W., and Frei, B., Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol. Proc. Natl. Acad. Sci. U.S.A., 88, 1646, 1991.
99. Suarna, C., Hood, R. L., Dean, R. T., and Stocker, R., Comparative antioxidant activity of tocotrienols and other natural lipid-soluble antioxidants in a homogeneous system, and in rat and human lipoproteins, Biochim. Biophys. Acta, 1166, 163, 1993.
100. Mohr, D., Bowry, V. S., and Stocker, R., Dietary supplementation with coenzyme Q10 results in increased levels of ubiquinol-10 within circulating lipoproteins and increased resistance of human low-density lipoprotein to the initiation of lipid peroxidation, Biochim. Biophys. Acta, 1126, 246, 1992.
101. Bierman, E. L., Atherogenesis in diabetes, Arterioscler. Thromb., 12, 647, 1992.
102. Babiy, A. V., Gebicki, J. M., Sullivan, D. R., and Willey, K., Increased oxidizability of plasma lipoproteins in diabetic patients can be decreased by probucol therapy and is not due to glycation, Biochem. Pharmacol., 43, 995, 1992.
103. Church, D. F. and Pryor, W. A., Free-radical chemistry of cigarette smoke and its toxicological implications, Environ. Health Perspect., 64, 111, 1985.
104. Ziegler, R. G., Wilcox, H. B., III, Mason, T. J., Bill, J. S., and Virgo, P. W., Seasonal variation in intake of carotenoids and vegetables and fruits among white men in New Jersey, Am. J. Clin. Nutr., 45, 107, 1987.
105. Dimascio, P., Kaiser, S., and Sies, H., Lycopene as the most efficient biological carotenoid singlet oxygen quencher, Arch. Biochem. Biophys., 274, 532, 1989.
106. Herbert, V., Everyone should be tested for iron disorders, J. Am. Dietet. Assoc., 92, 1502, 1992.
107. Weber, P. C., Fish oil fatty acids and cardiovascular function: epidemiology and biochemical mechanisms, Biochem. Soc. Trans., 18, 1045, 1990.
108. Gonzalez, M. J., Gray, J. L, Schemmel, R. A., Dugan, R., Jr., and Welsch, C. W., Lipid peroxidation products are elevated in fish oil diets even in the presence of added antioxidants, J. Nutr., 122, 2190, 1992.
109. Bonanome, A., Pagnan, A., Biffanti, S., Opportune, A., Sorgato, F., Dorella, M., Maiorino, M., and Ursini, F., Effect of dietary monounsaturated and polyunsaturated fatty acids on the susceptibility of plasma low density lipoproteins to oxidative modification, Arterioscler. Thromb., 12, 529, 1992.
110. Reaven, P. D., Grasse, B. J., and Tribble, D. L., Effects of linoleate-enriched and oleate-enriched diets in combination with α-tocopherol on the susceptibility of LDL and LDL subfractions to oxidative modification in humans, Arterioscler. Thromb., 14, 557, 1994.
111. DeMaio, S. J., King, S. B., III, Lembo, N. J., Roubin, G. S., Hearn, J. A., Bhagavan, H. N., and Sgoutas, D. S., Vitamin E supplementation, plasma lipids and incidence of restenosis after percutaneous transluminal coronary angioplasty (TCA), J. Am. Coll. Nutr., 11, 68, 1992.
112. Frankel, E. N., Kanner, J., German, J. B., Parks, E., and Kinsella, J. E., Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine, Lancet, 341, 454, 1993.
113. Nègre-Salvayre, A. and Salvayre, R., Quercetin prevents the cytotoxicity of oxidized LDL on lymphoid cell lines, Free Radical Biol. Med., 12, 101, 1992.
114. Ramanathan, R., Das, N. P., and Tan, C. H., Effects of α-linolenic acid, flavonoids, and vitamins on cytotoxicity and lipid peroxidation, Free Radical Biol. Med., 16, 43, 1994.
115. Rankin, S. M., DeWhalley, C. V., Hoult, J. R. S., Jessup, W., Wilkins, G. M., Collard, J., and Leake, D. S., The modification of low density lipoprotein by the flavonoids myricetin and gossypetin, Biochem. Pharmacol., 45, 67, 1993.